Methylthiouracil NEW
| Price | $40 | $50 | $74 |
| Package | 25mg | 50mg | 100mg |
| Supply Ability: | 10g |
| Update Time: | 2026-04-21 |
Product Details
| Product Name: Methylthiouracil | CAS No.: 56-04-2 |
| Purity: 99.89% | Supply Ability: 10g |
| Release date: 2026/04/21 |
Product Introduction
Bioactivity
| Name | Methylthiouracil |
| Description | Methylthiouracil is a thiourea-class antithyroid agent that inhibits the synthesis of thyroid hormones and is commonly used to treat hyperthyroidism. Studies have shown that Methylthiouracil can also suppress the production of TNF-α and IL-6, as well as inhibit the activation of NF-κB and ERK1/2. It can be used to induce hyperlipidemia and neurological disorder models. |
| In vitro | Methylthiouracil acts to decrease the formation of stored thyroid hormone, as thyroglobulin in the thyroid gland. Methylthiouracil is also used in combination with radioactive iodine. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | Ethanol : < 1 mg/mL (insoluble or slightly soluble) DMSO : 27 mg/mL (189.9 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (14.07 mM), Sonication is recommended. |
| Keywords | Tumor Necrosis Factor Receptor | TNFR | TNF Receptor | Nuclear factor-κB | Nuclear factor-kappaB | NSC9378 | NSC193526 | NSC 9378 | NSC 193526 | NF-κB | NFκB | NF-kB | NFkB | Methylthiouracil | Interleukin Related | Interleukin | Inhibitor | inhibit | Extracellular signal regulated kinases | ERK | antithyroid |
| Inhibitors Related | Kaolin | Urea | Rhamnose monohydrate | Kojic acid | Gum arabic | D(+)-Raffinose pentahydrate | Hydroxypropyl Cellulose | 1,8-Cineole | Sodium formate | Ethyl linoleate | D-Psicose | Gluconate Calcium |
| Related Compound Libraries | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Kinase Inhibitor Library | Anti-Viral Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bitter Compound library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $40.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-04-21 | |
| $10.00 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2026-03-20 | ||
| $556.00 |
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2025-12-24 | |
| $40.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-04-27 | |
| $2.00 |
Wuhan ShuEr Biology Technology Co.,Ltd
|
2022-09-29 | ||
| $10.00 |
Shanxi Naipu Import and Export Co.,Ltd
|
2022-02-25 | ||
| $917.00 |
Baoji Guokang Healthchem co.,ltd
|
2021-11-02 | ||
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-13 | ||
|
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2020-02-26 | ||
| $1.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-06 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY